Menu

• Ask a Health Expert about ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED
• Post Your Side Effect related to ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED
• ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED and FDA Warnings
• ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED in Patients Wiki
• Report ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED in Drug Side Effect Survey

ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED side effect

What is ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Ovcon Side Effects Report #5689506-5
Consumer or non-health professional from UNITED STATES reported OVCON problem on Mar 17, 2008. Female patient, 21 years of age, weighting 147.9 lb, was diagnosed with ovarian cyst and was treated with OVCON. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, aortic valve incompetence, cerebral infarction, cerebrovascular accident, convulsion, dna antibody positive, haemorrhage, metrorrhagia, migraine, . OVCON dosage: unknown. During the same period patient was treated with NORTRIPTYLINE. Patient was hospitalized and became disabled. Patient recovered.

Avonex Side Effects Report #5619204-5
AVONEX problem was reported by a Consumer or non-health professional from GERMANY on Jan 24, 2008. Female patient, 31 years of age, weighting 132.3 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, appendix disorder, blood sodium decreased, diarrhoea, gastroenteritis viral, haematocrit decreased, hypertrophy, laboratory test abnormal, red blood cell count decreased, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.

Arixtra Side Effects Report #5523382-6
Physician from RUSSIAN FEDERATION reported ARIXTRA problem on Nov 16, 2007. Male patient, 42 years of age, was diagnosed with myocardial infarction and was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, . ARIXTRA dosage: unknown. During the same period patient was treated with HEPARIN, THROMBOLYTIC AGENT. Patient died on 11/01/2007.

Doxil Side Effects Report #5526443-0
DOXIL problem was reported by a Physician from UNITED STATES on Nov 16, 2007. Male patient, weighting 238.0 lb, was diagnosed with multiple myeloma, hypertension, prophylaxis and was treated with DOXIL. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, acute prerenal failure, bacteraemia, catabolic state, confusional state, constipation, dehydration, diabetes mellitus, electrocardiogram st-t segment abnormal, . DOXIL dosage: unknown. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, DIOVAN, ACYCLOVIR. Patient was hospitalized. Patient recovered.


Docetaxel Side Effects Report #5482159-0
Health Professional from UNITED STATES reported DOCETAXEL problem on Oct 02, 2007. Male patient, 67 years of age, weighting 128.0 lb, was diagnosed with squamous cell carcinoma and was treated with DOCETAXEL. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, blood culture positive, blood glucose increased, blood ph increased, blood pressure decreased, blood sodium decreased, cardiac arrest, culture urine positive, escherichia infection, . DOCETAXEL dosage: unknown. Patient was hospitalized. Patient died on 06/29/2007.

Citalopram Side Effects Report #5494495-2
CITALOPRAM HYDROBROMIDE problem was reported by a Consumer or non-health professional from FRANCE on Oct 05, 2007. Female patient, 74 years of age, was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, blood glucose increased, blood pressure decreased, haematemesis, hypernatraemia, hypokalaemia, neutrophil count increased, normochromic normocytic anaemia, . CITALOPRAM HYDROBROMIDE dosage: 10 MG QD PO. During the same period patient was treated with LOVENOX, ASPIRIN, PRAVASTATIN, ATARAX, LAMALINE, NEURONTIN, FUNGIZONE, DIAMICRON. Patient was hospitalized. Patient recovered.

Zolinza Side Effects Report #5504785-2
Physician from UNITED STATES reported ZOLINZA problem on Oct 31, 2007. Female patient, 61 years of age, weighting 177.3 lb, was diagnosed with breast cancer metastatic and was treated with ZOLINZA. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, deep vein thrombosis, prothrombin time shortened, pulmonary embolism, thrombocytopenia, . ZOLINZA dosage: 400 MG DAILY 21 OF 28 DAYS P.O. 30 MG DAILY 21 DAY OF 28 DAYS PO. During the same period patient was treated with TAMOXIFEN CITRATE, ZOMETA, GLUCOSAMINE CHONDROITIN. Patient recovered.

Trileptal Side Effects Report #5441479-6
TRILEPTAL problem was reported by a Physician from GERMANY on Aug 27, 2007. Male patient, 52 years of age, weighting 211.6 lb, was diagnosed with convulsion prophylaxis, diabetes mellitus, hypertension, hyperlipidaemia, hyperuricaemia and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, blood creatinine increased, c-reactive protein increased, haematocrit decreased, haemoglobin decreased, international normalised ratio decreased, leukocyturia, mean cell haemoglobin increased, . TRILEPTAL dosage: 1200 MG/D, DECREASING . During the same period patient was treated with FALITHROM, AMARYL, RAMIPRIL, SIMVASTATIN, ALLOPURINOL. Patient recovered.

Argatroban Side Effects Report #5472251-9
Physician from UNITED STATES reported ARGATROBAN problem on Sept 10, 2007. Male patient, 59 years of age, weighting 142.0 lb, was diagnosed with heparin-induced thrombocytopenia and was treated with ARGATROBAN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, platelet count abnormal, . ARGATROBAN dosage: unknown. During the same period patient was treated with NORVASC, LASIX, PREDNISONE, DEXAMETHASONE, PROTONIX, SENNA, COLACE, INSULIN. Patient was hospitalized. Patient recovered.


Heparin Side Effects Report #5425953-4
HEPARIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2007. Male patient, 38 years of age, weighting 175.0 lb, was diagnosed with prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, extradural haematoma, mental status changes postoperative, . HEPARIN dosage: unknown. During the same period patient was treated with PHENYTOIN, RANITIDINE, INSULIN, DEXAMETHASONE, LEVETIRACETAM. Patient recovered.

Avelox Side Effects Report #5781748-3
Physician from GERMANY reported AVELOX problem on June 17, 2008. Female patient, 45 years of age, weighting 138.9 lb, was diagnosed with bronchitis and was treated with AVELOX. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, alanine aminotransferase increased, ammonia increased, antithrombin iii decreased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, blood creatinine increased, c-reactive protein increased, . AVELOX dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 400 MG. Patient was hospitalized. Patient recovered.

Avastin Side Effects Report #5787496-8
AVASTIN problem was reported by a Health Professional from UNITED STATES on June 23, 2008. Female patient, 42 years of age, weighting 99.20 lb, was diagnosed with non-small cell lung cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, blood sodium decreased, hypoxia, pneumonia, respiratory failure, . AVASTIN dosage: 15 MG/KG IV D-14 + Q21D. During the same period patient was treated with ABRAXANE, CALCIUM, KLONOPIN, FIORICET, ADVAIR DISKUS, PREDNISONE, PERCOCET. Patient was hospitalized. Patient recovered.

Argatroban Side Effects Report #5802555-9
Physician from UNITED STATES reported ARGATROBAN problem on Sept 10, 2007. Male patient, 59 years of age, weighting 142.0 lb, was diagnosed with heparin-induced thrombocytopenia and was treated with ARGATROBAN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, platelet count abnormal, . ARGATROBAN dosage: unknown. During the same period patient was treated with NORVASC, METOPROLOL TARTRATE, LASIX, PREDNISONE, DEXAMETHASONE, PROTONIX, SENNA, COLACE. Patient was hospitalized. Patient recovered.

Lapatinib Side Effects Report #5753898-9
LAPATINIB problem was reported by a Physician from UNITED KINGDOM on May 21, 2008. Female patient, 50 years of age, weighting 183.0 lb, was diagnosed with breast cancer metastatic, metastases to central nervous system, pain and was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, asthenia, blood potassium decreased, fall, hypokalaemia, platelet count decreased, . LAPATINIB dosage: 1500MG PER DAY. During the same period patient was treated with CAPECITABINE, DEXAMETHASONE, OXYCONTIN, OMEPRAZOLE, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5710549-7
Physician from UNITED STATES reported VELCADE problem on Apr 04, 2008. Female patient, 65 years of age, weighting 103.8 lb, was diagnosed with mantle cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, aortic valve incompetence, crepitations, dyspnoea, febrile neutropenia, haemorrhage, headache, hypokinesia, infection, . VELCADE dosage: 1.3 MG/M2, IV BOLUS. During the same period patient was treated with ETOPOSIDE, PREDNISONE, VINCRISTINE, CYCLOPHOSPHAMIDE, DOXORUBICIN, RITUXIMAB, FILGRASTIM, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Exelon Side Effects Report #5336724-1
EXELON problem was reported by a Physician from CANADA on May 17, 2007. Female patient, 75 years of age, was diagnosed with dementia alzheimer's type and was treated with EXELON. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, arteriosclerosis, atrial tachycardia, atrioventricular extrasystoles, bradyarrhythmia, carotid artery stenosis, cerebral ischaemia, computerised tomogram abnormal, red cell distribution width increased, . EXELON dosage: unknown. During the same period patient was treated with OPHTHALMOLOGICALS, ASPIRIN, SERAX, TYLENOL, BRIMONIDINE TARTRATE. Patient was hospitalized. Patient recovered.

Natalizumab Side Effects Report #5292566-7
Physician from GERMANY reported NATALIZUMAB problem on Mar 22, 2007. Male patient, 50 years of age, weighting 154.3 lb, was diagnosed with secondary progressive multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, asthenia, blood sodium increased, disease progression, dizziness, dyspnoea, haematocrit decreased, headache, influenza, . NATALIZUMAB dosage: 300 MG;QM;IV. During the same period patient was treated with ASPIRIN, VIGIL, LIORESAL, DANTAMACRINE, MYDOCALM, VITAMIN E, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.

Isotretinoin Side Effects Report #5294983-8
ISOTRETINOIN problem was reported by a Physician from BRAZIL on Apr 03, 2007. Male patient, 16 years of age, weighting 132.3 lb, was diagnosed with acne and was treated with ISOTRETINOIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, gastrointestinal haemorrhage, . ISOTRETINOIN dosage: unknown. Patient was hospitalized. Patient recovered.

Isotretinoin Side Effects Report #5308445-2
Physician from BRAZIL reported ISOTRETINOIN problem on Apr 17, 2007. Male patient, 16 years of age, weighting 132.3 lb, was diagnosed with acne and was treated with ISOTRETINOIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, gastrointestinal haemorrhage, . ISOTRETINOIN dosage: unknown. Patient was hospitalized. Patient recovered.


Taxotere Side Effects Report #5501705-1
TAXOTERE problem was reported by a Health Professional from IRELAND on Oct 24, 2007. Male patient, 72 years of age, was diagnosed with prostate cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: acquired diaphragmatic eventration, activated partial thromboplastin time shortened, back pain, blood fibrinogen decreased, blood glucose increased, haemoglobin decreased, hypotension, ill-defined disorder, metastases to spine, . TAXOTERE dosage: unknown. During the same period patient was treated with ZOLADEX, NEORECORMON, ZOMETA. Patient was hospitalized and became disabled. Patient recovered.

Argatroban Side Effects Report #5392843-5
Health Professional from GERMANY reported ARGATROBAN problem on July 02, 2007. Male patient, 53 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with ARGATROBAN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, activated partial thromboplastin time shortened, aspartate aminotransferase increased, blood bilirubin increased, coagulation time prolonged, haemorrhage, septic shock, . ARGATROBAN dosage: unknown. During the same period patient was treated with HEPARIN, ACYCLOVIR, CAPTOPRIL, VIAGRA, DIFLUCAN, ERYTHROMYCIN, VANCOMYCIN, RIFAMPICIN. Patient died on 09/02/2005.

Argatroban Side Effects Report #5392843-5
ARGATROBAN problem was reported by a Health Professional from GERMANY on July 02, 2007. Male patient, 53 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with ARGATROBAN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, activated partial thromboplastin time shortened, aspartate aminotransferase increased, blood bilirubin increased, coagulation time prolonged, haemorrhage, septic shock, . ARGATROBAN dosage: unknown. During the same period patient was treated with HEPARIN, ACYCLOVIR, CAPTOPRIL, VIAGRA, DIFLUCAN, ERYTHROMYCIN, VANCOMYCIN, RIFAMPICIN. Patient died on 09/02/2005.

Menotrophin Side Effects Report #5730130-3
Consumer or non-health professional from FRANCE reported MENOTROPHIN problem on Apr 16, 2008. Female patient, 31 years of age, was diagnosed with anovulatory cycle and was treated with MENOTROPHIN. After drug was administered, patient experienced the following problems/side effects: abortion induced, activated partial thromboplastin time shortened, brain oedema, cerebral artery occlusion, cerebral infarction, extensor plantar response, hemiplegia, hyponatraemia, . MENOTROPHIN dosage: unknown. During the same period patient was treated with CHORIONIC GONADOTROPIN. Patient was hospitalized. Patient recovered.